maintains

Business

Match Group target cut on mixed Q1 results, maintains buy By Investing.com

On Thursday, TD Cowen adjusted its outlook on Match Group (NASDAQ:), a leading provider of dating products, by reducing the…

Read More »
Politics

Donald Trump maintains lead over Joe Biden in new survey

Former President Trump maintains a lead over President Biden in a hypothetical matchup, a new survey found. Trump has 49…

Read More »
Business

Verizon stock maintains Outperform rating with $48 target By Investing.com

On Tuesday, Oppenheimer has maintained its Outperform rating on Verizon Communications (NYSE:) with a steady price target of $48.00. The…

Read More »
Business

Wells Fargo maintains Estee Lauder at overweight with $175 target By Investing.com

On Wednesday, Wells Fargo reiterated its Overweight rating on Estee Lauder shares (NYSE:), maintaining a price target of $175.00. The…

Read More »
Business

Itau BBA maintains Marfrig Global Foods stock rating at Market Perform By Investing.com

On Tuesday, Itau BBA maintained its Market Perform rating and a R$10.00 stock price target on Marfrig Global Foods SA…

Read More »
Business

Citi raises Ovintiv shares price target to $64, maintains buy rating By Investing.com

On Tuesday, Citi updated its outlook on Ovintiv Inc. (NYSE:), increasing the stock’s price target to $64 from the previous…

Read More »
Business

Ulta Beauty maintains 2024 outlook amid beauty sector slowdown By Investing.com

Ulta Beauty, Inc. (NASDAQ: NASDAQ:) has reaffirmed its full-year fiscal 2024 guidance despite observing moderating growth trends in the U.S.…

Read More »
Business

CFRA cuts PVH Corp price target to $138, maintains buy rating By Investing.com

On Tuesday, CFRA research firm adjusted its financial outlook on PVH Corp (NYSE:), a global apparel company. The firm lowered…

Read More »
Business

Truist maintains Buy on Rivian shares as revenue beats estimates By Investing.com

© Reuters On Thursday, Truist Securities maintained its Buy rating on Rivian (NASDAQ:) Automotive Inc (NASDAQ:RIVN) with a consistent price…

Read More »
Business

BMO maintains Outperform on Silence Therapeutics citing clinical advancements By Investing.com

© Reuters. Tuesday, Silence Therapeutics (NASDAQ:SLN) maintained its Outperform rating and $67.00 price target from BMO Capital. The firm’s continued…

Read More »
Back to top button